These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 5575079)
21. Restrictions on import of drugs for personal use within the European single market. Mäkinen MM; Rautava PT; Forsström JJ Eur J Public Health; 2002 Dec; 12(4):244-8. PubMed ID: 12506498 [TBL] [Abstract][Full Text] [Related]
22. Patterns and problems of drug introduction and control. Káldor A Int J Clin Pharmacol; 1973 Apr; 7(2):163-7. PubMed ID: 4731282 [No Abstract] [Full Text] [Related]
23. [Problems of drug abuse (notes on legislation)]. Cesk Zdrav; 1972 Mar; 20(3):140-1. PubMed ID: 5012714 [No Abstract] [Full Text] [Related]
24. The evolution of human medicines control from a national to an international perspective. Griffin JP Adverse Drug React Toxicol Rev; 1998 Mar; 17(1):19-50. PubMed ID: 9638280 [No Abstract] [Full Text] [Related]
25. [Problems of guarantee control of drugs]. Christoph KH Pharm Prax; 1967; 10():285-8. PubMed ID: 5615142 [No Abstract] [Full Text] [Related]
27. [European drug policy: welcomed modernization but shortage of political proposals concerning industry and research]. Alván G Lakartidningen; 2003 Oct; 100(44):3541-2. PubMed ID: 14651017 [No Abstract] [Full Text] [Related]
28. [Goals and properties of the Bureau of Drug Control]. Bruinsma W Ned Tijdschr Geneeskd; 1972 Feb; 116(9):343-4. PubMed ID: 5010441 [No Abstract] [Full Text] [Related]
29. Drug regulatory problems in smaller countries. Scott AI Hosp Formul; 1976 May; 11(5):255-9. PubMed ID: 1026688 [No Abstract] [Full Text] [Related]
30. [The international control of narcotics during the past 40 years]. Vaille C Presse Med (1893); 1968 Apr; 76(19):939-41. PubMed ID: 4868842 [No Abstract] [Full Text] [Related]
31. [Technical discussions at the 20th Panamerican Health Conference. Repercussions of the cost of drugs on the cost of health: national and international problems]. Bol Oficina Sanit Panam; 1979 Dec; 87(6):471-93. PubMed ID: 161718 [No Abstract] [Full Text] [Related]
32. Law, medicines and the doctor: a critical look at drug regulation. Dukes MN Curr Med Res Opin; 1973; 1(10):612-28. PubMed ID: 4778727 [No Abstract] [Full Text] [Related]
33. [European drug policy]. Sauer F Bull Mem Acad R Med Belg; 1993; 148(5-6):207-12; discussion 212-6. PubMed ID: 8142930 [TBL] [Abstract][Full Text] [Related]
34. [International aspects of cannabis]. Martens S Lakartidningen; 1976 Nov; 73(45):3874-5. PubMed ID: 979455 [No Abstract] [Full Text] [Related]
35. Reflections on some international and Swedish legal rules relating to drug offenses. Bogdan M; Falk P Bull Narc; 1977; 29(3):1-20. PubMed ID: 244309 [No Abstract] [Full Text] [Related]
36. Drug regulation and policy formulation. Nightingale SL Milbank Mem Fund Q Health Soc; 1981; 59(3):412-44. PubMed ID: 7024847 [TBL] [Abstract][Full Text] [Related]
37. [Should we accept defective copies?]. Ostholm I Lakartidningen; 1993 Oct; 90(43):3747-8. PubMed ID: 8231521 [No Abstract] [Full Text] [Related]
38. Study on exempted preparations. Halbach H Bull Narc; 1983; 35(1):17-40. PubMed ID: 6555054 [TBL] [Abstract][Full Text] [Related]
39. [Responsibility for drug testing and control]. Büchi J Pharm Acta Helv; 1968 Sep; 43(9):619-27. PubMed ID: 5718866 [No Abstract] [Full Text] [Related]
40. [Perspectives of European health cooperation]. Blancher G Bull Acad Natl Med; 1971 Feb; 155(5):105-6. PubMed ID: 4930391 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]